Tert-butyl 4-[2-[1-(5-bromo-2-pyridinyl)piperidin-4-yl]-2,2-difluoroethyl]piperazine-1-carboxylate
C21H31BrF2N4O2 — CID 165371160
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[2-[1-(5-bromo-2-pyridinyl)piperidin-4-yl]-2,2-difluoroethyl]piperazine-1-carboxylate
Tert-butyl 4-[2-[1-(5-bromo-2-pyridinyl)piperidin-4-yl]-2,2-difluoroethyl]piperazine-1-carboxylate (PubChem CID 165371160) has the molecular formula C21H31BrF2N4O2 and a molecular weight of 489.41 g/mol. Its IUPAC name is tert-butyl 4-[2-[1-(5-bromo-2-pyridinyl)piperidin-4-yl]-2,2-difluoroethyl]piperazine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 4-[2-[1-(5-bromo-2-pyridinyl)piperidin-4-yl]-2,2-difluoroethyl]piperazine-1-carboxylate |
|---|---|
| PubChem CID | 165371160 |
| Molecular Formula | C21H31BrF2N4O2 |
| Molecular Weight | 489.41 g/mol |
| Exact Mass | 488.16 |
| IUPAC Name | tert-butyl 4-[2-[1-(5-bromo-2-pyridinyl)piperidin-4-yl]-2,2-difluoroethyl]piperazine-1-carboxylate |
| SMILES | CC(C)(C)OC(=O)N1CCN(CC(F)(F)C2CCN(c3ccc(Br)cn3)CC2)CC1 |
| InChI | InChI=1S/C21H31BrF2N4O2/c1-20(2,3)30-19(29)28-12-10-26(11-13-28)15-21(23,24)16-6-8-27(9-7-16)18-5-4-17(22)14-25-18/h4-5,14,16H,6-13,15H2,1-3H3 |
| InChIKey | WBORIIQSDDSADA-UHFFFAOYSA-N |
| XLogP | 4.25 |
| TPSA | 48.91 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 489.41 |
| LogP ≤ 5 | 4.25 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 165371160 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.